These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12563294)

  • 1. Hide, shield and strike back: how HIV-infected cells avoid immune eradication.
    Peterlin BM; Trono D
    Nat Rev Immunol; 2003 Feb; 3(2):97-107. PubMed ID: 12563294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis as an HIV strategy to escape immune attack.
    Gougeon ML
    Nat Rev Immunol; 2003 May; 3(5):392-404. PubMed ID: 12766761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV. Escape artist par excellence.
    Cohen J
    Science; 2003 Mar; 299(5612):1505-8. PubMed ID: 12624245
    [No Abstract]   [Full Text] [Related]  

  • 4. Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells.
    Hinkula J; Walther-Jallow L; Laurén A; Mäkitalo B; Oberg M; Wahren B; Fenyö EM; Spetz AL
    Vaccine; 2009 Oct; 27(46):6424-31. PubMed ID: 19549607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host genetic factors that control immune responses to retrovirus infections.
    Miyazawa M; Tsuji-Kawahara S; Kanari Y
    Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infection.
    Biswas P; Ferrarini M; Mantelli B; Fortis C; Poli G; Lazzarin A; Manfredi AA
    Eur J Immunol; 2003 Jan; 33(1):252-63. PubMed ID: 12594854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4+ T cells.
    Thibault S; Imbeault M; Tardif MR; Tremblay MJ
    Virology; 2009 Jun; 389(1-2):20-5. PubMed ID: 19447460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism and history of evolution of symbiotic HIV strains into lethal pandemic strains: the key event may have been a 1927 trial of pamaquine in Leopoldville (Kinshasa), Congo.
    Parris GE
    Med Hypotheses; 2007; 69(4):838-48. PubMed ID: 17368749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hitting HIV where it hurts: an alternative approach to HIV vaccine design.
    Altfeld M; Allen TM
    Trends Immunol; 2006 Nov; 27(11):504-10. PubMed ID: 16997629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV replication elicits little cytopathic effects in vivo: analysis of surrogate markers for virus production, cytotoxic T cell response and infected cell death.
    Funk GA; Oxenius A; Fischer M; Opravil M; Joos B; Flepp M; Weber R; Günthard HF; Bonhoeffer S
    J Med Virol; 2006 Sep; 78(9):1141-6. PubMed ID: 16847964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latency: the hidden HIV-1 challenge.
    Marcello A
    Retrovirology; 2006 Jan; 3():7. PubMed ID: 16412247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immune control model for viral replication in the CNS during presymptomatic HIV infection.
    McCrossan M; Marsden M; Carnie FW; Minnis S; Hansoti B; Anthony IC; Brettle RP; Bell JE; Simmonds P
    Brain; 2006 Feb; 129(Pt 2):503-16. PubMed ID: 16317019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy.
    Sarmati L; Nicastri E; Montano M; Dori L; Buonomini AR; d'Ettorre G; Gatti F; Parisi SG; Vullo V; Andreoni M
    J Med Virol; 2004 Apr; 72(4):511-6. PubMed ID: 14981751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cornering HIV: taking advantage of interactions between selective pressures.
    Avila-Ríos S; Reyes-Terán G; Espinosa E
    Med Hypotheses; 2007; 69(2):422-31. PubMed ID: 17280799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical models of HIV and the immune system.
    Wodarz D
    Novartis Found Symp; 2003; 254():193-207; discussion 207-22, 250-2. PubMed ID: 14712939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine-induced T cells control reversion of AIDS virus immune escape mutants.
    Fernandez CS; Smith MZ; Batten CJ; De Rose R; Reece JC; Rollman E; Venturi V; Davenport MP; Kent SJ
    J Virol; 2007 Apr; 81(8):4137-44. PubMed ID: 17251297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication of HIV in infected patients: some potential approaches.
    Yang QE
    Med Sci Monit; 2004 Jul; 10(7):RA155-65. PubMed ID: 15232518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why vaccines are not the answer - the failure of V520 and the importance of cell-mediated immunity in the fight against HIV.
    White A
    Med Hypotheses; 2008 Dec; 71(6):909-13. PubMed ID: 18768264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of HIV.
    Kaplan MH
    Infect Dis Clin North Am; 1994 Jun; 8(2):279-88. PubMed ID: 7916357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.